Z. TOPAL Et Al. , "Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study," 5th International Congress on Psychopharmacology , Antalya, Turkey, 2013
TOPAL, Z. Et Al. 2013. Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study. 5th International Congress on Psychopharmacology , (Antalya, Turkey).
TOPAL, Z., DEMİR, N., TUMAN, T. C., & TUFAN, A. E., (2013). Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study . 5th International Congress on Psychopharmacology, Antalya, Turkey
TOPAL, ZEHRA Et Al. "Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study," 5th International Congress on Psychopharmacology, Antalya, Turkey, 2013
TOPAL, ZEHRA Et Al. "Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study." 5th International Congress on Psychopharmacology , Antalya, Turkey, 2013
TOPAL, Z. Et Al. (2013) . "Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study." 5th International Congress on Psychopharmacology , Antalya, Turkey.
@conferencepaper{conferencepaper, author={ZEHRA TOPAL Et Al. }, title={Tolerability of OROS methlyphenidate in Turkish children and adolescents with attention-deficit/ hyperactivity disorder may not be affected by dose or augmentation with risperidone: a preliminary study}, congress name={5th International Congress on Psychopharmacology}, city={Antalya}, country={Turkey}, year={2013}}